Company / Current Assets per Share
Arcadia Biosciences, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.66
FY2025
5-year range
$2.63 / $45.79
FY2021-FY2025
Trend
-35.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $45.79 in FY2022 to $4.66 in FY2025.
Based on SEC 10-K filings.
4.66 in FY2025 with a 5-year CAGR of +4.9%.
Declined from $24.30 to $4.66 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -53.3%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 35.2% year-over-year.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.66 | -35.2% |
| FY2024 | $7.19 | -70.4% |
| FY2023 | $24.30 | -46.9% |
| FY2022 | $45.79 | +1640.6% |
| FY2021 | $2.63 | -28.2% |
| FY2020 | $3.67 | -38.5% |
| FY2019 | $5.96 | -44.4% |
| FY2018 | $10.72 | +58.5% |
| FY2017 | $6.76 | +472.3% |
| FY2016 | $1.18 | -95.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026